MS ECHO training for rural, frontline healthcare providers. This training was designed to better inform local providers, recognizing that many rural residents face barriers to accessing neurological care. The sessions take place once per month, the first Wednesday of the month for an hour. Participants can attend as many sessions as they would like, all…
Month: January 2024
Accessible Living: Renovation Tips
If you want to age in place or have a disability that requires modifying your home to make your life easier and more comfortable, you must learn about accessible living. When renovating, you’ll want to consult professionals specializing in universal design or accessibility modifications. They can provide expert advice tailored to your needs and ensure…
Blood levels of GFAP protein may predict disease progression in PPMS
Risk of disability worsening nearly 3 times greater with high GFAP: Study The ongoing worsening of disability among people with primary progressive multiple sclerosis (PPMS) may be predicted by elevated blood levels of the GFAP protein, a marker of damage to star-shaped support cells in the brain and spinal cord called astrocytes, a study suggests. The risk…
The MS Views and News Learning Channel, Presents: THE 2023 MS SYMPOSIUM – watch these educational videos with MS Neurologists Boster, Rosenthal, Steingo and more
PLAYING 2023 MS Symposium (Part 1 of 5) – LIVING WELL with MS, Pain Management, Biomarkers and More 40:26 NOW PLAYING 2023 MS Symposium (Part 2 of 5) – Mental Wellness in MS – Emotions, Mood Changes and more 57:57 NOW PLAYING 2023 MS Symposium (Part 3 of 5) – Bladder and Sexual Issues…
EU agency OKs study of therapy to improve mitochondrial function
Trial of MP101 to enroll patients with MS, other neurodegenerative diseases by Andrea Lobo, PhD | January 16, 2024 Mitochon Pharmaceuticals is launching a pilot clinical trial to evaluate MP101, its treatment candidate for improving mitochondrial function, in people with multiple sclerosis (MS) and other neurodegenerative diseases. The announcement follows the trial’s clearance by the European Medicines Agency (EMA), which enables…
Dehydration and bladder function — Are you dehydrating yourself to manage your bladder problems?
GAVIN GIOVANNONI – JAN 9, 2024 Dehydration is not a good way to control your bladder symptoms. Almost 30 years ago, while doing my PhD on a urine biomarker of inflammation, I noted that urinary concentration of creatinine, a muscle metabolite excreted in the urine, correlated with disability. I soon worked out that people with MS with…
High-Intensity Gait Training in an Individual With Neuromyelitis Optica and Research Recommendations for Individuals With Multiple Sclerosis
Abstract Background: Neuromyelitis optica (NMO), similar to multiple sclerosis (MS), is an autoimmune disorder affecting the central nervous system. In people with central nervous system diagnoses, high-intensity gait training (HIGT) can support neuroplasticity, improving functional mobility. While low- to moderate-intensity exercise is beneficial in improving outcomes in individuals with NMO and MS, the impact…